NPs Basic Information

Name
4-Hydroxy-6-methyl-2-pyrone
Molecular Formula C6H6O3
IUPAC Name*
4-hydroxy-6-methylpyran-2-one
SMILES
CC1=CC(=CC(=O)O1)O
InChI
InChI=1S/C6H6O3/c1-4-2-5(7)3-6(8)9-4/h2-3,7H,1H3
InChIKey
NSYSSMYQPLSPOD-UHFFFAOYSA-N
Synonyms
4-Hydroxy-6-methyl-2-pyrone; 675-10-5; 2-Hydroxy-6-methyl-4H-pyran-4-one; 4-Hydroxy-6-methyl-2H-pyran-2-one; 70254-61-4; 4-hydroxy-6-methylpyran-2-one; Triacetic acid lactone; Triacetate lactone; 2H-PYRAN-2-ONE, 4-HYDROXY-6-METHYL-; 6-Methyl-4-hydroxypyron-(2); NSC 34625; MFCD00006641; CHEMBL54907; S1S883S4EE; 6-Methyl-4-hydroxypyran-2-one; CHEBI:16458; 6-methyl-4-oxidanyl-pyran-2-one; NSC-34625; 3,5-Dihydroxysorbic acid delta-lactone; 6-methyl-4-hydroxy-2-pyrone; 4-Hydroxy-6-methylpyran-4-one; CCRIS 3600; EINECS 211-619-2; BRN 0113815; UNII-S1S883S4EE; 4H-Pyran-4-one, 2-hydroxy-6-methyl-; Spectrum_001904; SpecPlus_000816; Spectrum2_001978; Spectrum3_001720; Spectrum4_001907; Spectrum5_000594; 4-hydroxy-6-methylpyrone; 6-methyl-4-hydroxypyrone; 4-hydroxy-6-methyl-pyrone; 4-hydroxy-6-methylpyranone; 4-hydroxy-6-methyl pyranone; BSPBio_003340; KBioGR_002500; KBioSS_002438; 4-hydoxy-6-methyl-2-pyrone; DivK1c_006912; SCHEMBL320025; SCHEMBL918518; SPECTRUM1600759; SPBio_002135; 4- hydoxy-6-methyl-2-pyrone; 4-hydroxy- 6-methyl-2-pyrone; 4-hydroxy-6 -methyl-2-pyrone; 4-hydroxy-6-methyl pyr-2-one; DTXSID1060974; KBio1_001856; KBio2_002432; KBio2_005000; KBio2_007568; KBio3_002560; 4-hydroxy-6-methyl-pyran-2-one; 6-methyl-4-hydroxy pyran-2-one; 3,5-Dihydroxysorbic acid d-lactone; ALBB-021321; AMY23278; NSC34625; ZINC4273393; BBL008420; BDBM50405204; CCG-39516; MFCD18820248; STK772128; 4-Hydroxy-6-methyl-2-pyrone, 98%; AKOS000119605; AKOS016007260; ZINC100045433; CS-W020045; SDCCGMLS-0066925.P001; NCGC00095976-01; NCGC00095976-02; NCGC00178130-01; AC-27196; DA-17115; SY001948; 4-HYDROXY-6-METHYL-.ALPHA.-PYRONE; DB-055039; CS-0061284; FT-0618665; FT-0715301; H0715; EN300-20217; 75H105; 7H-939; C02752; F14831; O10801; A866649; SR-05000002374; Q7839869; SR-05000002374-1; W-104713; BRD-K77202630-001-02-9; BRD-K77202630-001-03-7; SORBIC ACID, 3,5-DIHYDROXY-, .DELTA.-LACTONE; F0001-1779; Z104477314; KJ6
CAS 675-10-5
PubChem CID 54675757
ChEMBL ID CHEMBL54907
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Pyrans
        • Subclass: Pyranones and derivatives
          • Direct Parent: Pyranones and derivatives

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 126.11 ALogp: 0.5
HBD: 1 HBA: 3
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 46.5 Aromatic Rings: 1
Heavy Atoms: 9 QED Weighted: 0.565

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.627 MDCK Permeability: 0.00003070
Pgp-inhibitor: 0 Pgp-substrate: 0.944
Human Intestinal Absorption (HIA): 0.006 20% Bioavailability (F20%): 0.049
30% Bioavailability (F30%): 0.836

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.066 Plasma Protein Binding (PPB): 71.01%
Volume Distribution (VD): 0.645 Fu: 44.53%

ADMET: Metabolism

CYP1A2-inhibitor: 0.299 CYP1A2-substrate: 0.772
CYP2C19-inhibitor: 0.037 CYP2C19-substrate: 0.115
CYP2C9-inhibitor: 0.012 CYP2C9-substrate: 0.851
CYP2D6-inhibitor: 0.02 CYP2D6-substrate: 0.642
CYP3A4-inhibitor: 0.007 CYP3A4-substrate: 0.217

ADMET: Excretion

Clearance (CL): 8.969 Half-life (T1/2): 0.781

ADMET: Toxicity

hERG Blockers: 0.015 Human Hepatotoxicity (H-HT): 0.062
Drug-inuced Liver Injury (DILI): 0.415 AMES Toxicity: 0.059
Rat Oral Acute Toxicity: 0.108 Maximum Recommended Daily Dose: 0.048
Skin Sensitization: 0.253 Carcinogencity: 0.657
Eye Corrosion: 0.956 Eye Irritation: 0.988
Respiratory Toxicity: 0.564
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC004676 0.442 D0FA2O 0.315
ENC001617 0.442 D07EXH 0.297
ENC005178 0.442 D0N0OU 0.282
ENC001542 0.442 D06GIP 0.233
ENC005370 0.442 D02UFG 0.231
ENC001539 0.429 D0E9CD 0.227
ENC005125 0.429 D04AIT 0.224
ENC006014 0.413 D0G4KG 0.222
ENC003365 0.413 D08ZEB 0.222
ENC000353 0.371 D07GRH 0.222
*Note: the compound similarity was calculated by RDKIT.